
Mycoplasma Pneumonia: How It Differs from Other Types of Respiratory Illnesses
, by Tatianna Gerard, 16 min reading time
, by Tatianna Gerard, 16 min reading time
Not all respiratory infections are created equal — and mycoplasma pneumonia is a perfect example of that.
Sometimes called “walking pneumonia,” mycoplasma pneumonia is a milder, slower-burning infection that can linger for weeks without the telltale intensity of high fevers or chest-rattling coughs you'd expect from regular pneumonia. That’s what makes it tricky: it feels like a stubborn cold or a persistent flu, but underneath the surface, it’s quietly inflaming your lungs.
Unlike typical bacterial pneumonia, which often strikes suddenly and severely, or viral infections like the flu or RSV, mycoplasma pneumonia spreads gradually — and often goes unnoticed until the cough just won’t go away. While it’s usually not life-threatening, it still needs proper care, especially if left untreated. Some people recover quickly with rest and antibiotics, but for others, symptoms like a nagging dry cough can hang on far longer than expected.
We’ll explore what makes mycoplasma pneumonia different from other common respiratory illnesses — from symptoms and diagnosis to treatment and recovery — so you can better recognise the signs and know what to expect if it comes your way.
Mycoplasma pneumonia is a type of atypical bacterial pneumonia, caused by the bacterium Mycoplasma pneumoniae. Unlike many other bacteria that cause respiratory infections, this one doesn’t have a cell wall — and that unique feature changes everything, from how it behaves in the body to how it's treated.
The term atypical doesn't mean it's rare or unusual — in fact, mycoplasma pneumonia is one of the most common causes of community-acquired pneumonia in younger people. Rather, it means that the illness presents in a way that’s different from “typical” bacterial pneumonia. It tends to be:
Milder in symptoms (especially early on)
Slower to develop (symptoms worsen gradually over days to weeks)
Harder to detect on initial physical exams
This slow build-up is why it’s often referred to as "walking pneumonia" — people might still go about their day thinking they just have a cold, while their lungs are quietly inflamed.
No cell wall: This is a key distinction. Because M. pneumoniae lacks a rigid outer wall, it’s resistant to certain antibiotics like penicillin and cephalosporins, which work by targeting bacterial cell walls.
Small and stealthy: It’s one of the smallest known free-living organisms capable of causing disease in humans. It can attach to the lining of the lungs and airways, triggering inflammation and disrupting normal respiratory function.
Transmitted through respiratory droplets: The bacteria spread via coughing, sneezing, or close contact — making it especially common in shared indoor spaces like schools, offices, and aged care facilities.
While mycoplasma pneumonia can affect people of all ages, it’s most common in:
School-aged children and young adults
People living in crowded environments (dormitories, military housing, shared accommodations etc.
Older adults or those with weakened immune systems, where symptoms may be more severe
The incubation period (the time from exposure to first symptoms) is typically 1 to 3 weeks, which is longer than most viral infections. This delayed onset can make it hard to trace back where or when someone was exposed.
While “pneumonia” is often used as a catch-all term for lung infections, there are actually several different types, each caused by different pathogens — and they don’t all behave the same. Mycoplasma pneumonia falls under the category of atypical pneumonia, which tends to be milder but more elusive in diagnosis.
Let’s break down the key differences between mycoplasma pneumonia and two other common types: typical bacterial pneumonia and viral pneumonia.
Feature |
Mycoplasma Pneumonia |
Typical Bacterial Pneumonia |
Viral Pneumonia |
Cause |
Mycoplasma pneumoniae (atypical bacterium) |
Streptococcus pneumoniae or similar (typical bacteria) |
Influenza, RSV, COVID-19, etc. |
Onset |
Gradual (develops over days or weeks) |
Sudden (within hours to a day) |
Gradual (similar to a worsening cold or flu) |
Fever |
Mild to moderate |
High and abrupt |
Mild to moderate |
Cough |
Persistent, dry cough |
Productive (mucus/phlegm) |
Dry or wet depending on virus |
Fatigue |
Noticeable but slow-building |
Severe and sudden |
Varies – moderate to intense |
Chest Pain |
Often mild or absent |
Sharp, worse with breathing or coughing |
Tightness or discomfort |
Response to Antibiotics |
Needs specific antibiotics (e.g. macrolides) |
Responds well to standard antibiotics |
Not treated with antibiotics unless secondary infection occurs |
Chest X-ray |
Widespread, patchy infiltrates that don't match physical symptoms |
Localised consolidation in one or more lobes |
Diffuse or patchy changes throughout both lungs |
Onset and symptoms
Mycoplasma pneumonia is deceptively slow to develop. A person may just feel a little “off” for several days — mild fever, scratchy throat, general tiredness — before the cough kicks in.
Typical bacterial pneumonia, by contrast, tends to hit hard and fast, often with high fever, chills, chest pain, and difficulty breathing.
Cause and response to treatment
Since Mycoplasma pneumoniae lacks a cell wall, many standard antibiotics won’t work. Medications like azithromycin or doxycycline are usually prescribed.
Viral pneumonia, meanwhile, can’t be treated with antibiotics at all. It requires supportive care unless there’s a secondary bacterial infection.
Chest imaging
One hallmark of mycoplasma pneumonia is that it may show widespread changes on a chest X-ray, even when the patient’s symptoms are relatively mild. This mismatch often surprises doctors and is a clue pointing toward an atypical infection.
Severity and risk
Mycoplasma pneumonia is generally less severe than bacterial pneumonia, especially in healthy people — but it can linger and cause prolonged cough or post-infection fatigue.
In vulnerable groups (older adults, people with asthma or COPD), any type of pneumonia — including mycoplasma — can still lead to serious complications.
One of the reasons mycoplasma pneumonia often flies under the radar is that its symptoms can closely resemble other respiratory illnesses — especially in the early stages. Many people mistake it for a cold, mild flu, or even seasonal allergies. This overlap makes it tricky to diagnose without proper testing, and as a result, people may not seek medical help until the infection has already progressed.
Persistent dry cough (often lasting weeks)
Low-grade fever (may be absent in some cases)
Sore throat
Fatigue and malaise
Headache
Mild chest discomfort
Wheezing or shortness of breath (especially in those with asthma)
Ear pain or irritation (due to inflammation spreading to ear canals)
Chills or muscle aches (infrequent but possible)
Many of these are non-specific symptoms — meaning they show up in multiple illnesses. That’s why mycoplasma pneumonia can be easily mistaken for:
The common cold
A lingering flu infection
A bout of bronchitis
A mild case of COVID-19 or RSV
Respiratory infections — whether bacterial or viral — all affect the same general area: the upper and lower airways. And while each pathogen behaves slightly differently, the body often responds in similar ways: coughing, inflammation, fatigue, and mucous production.
Another reason it can be hard to detect is the absence of hallmark “sick” signs:
No high fever? Might not feel urgent.
Cough isn’t producing much phlegm? Might not seem serious.
Still managing daily activities? Might assume it’ll pass on its own.
You should consider getting checked for mycoplasma pneumonia if:
A cough lasts longer than 7–10 days without improvement
You feel unusually tired or foggy despite resting
You have a mild fever that lingers for more than a few days
You're experiencing shortness of breath or chest tightness with no clear cause
Cold or flu symptoms seem to get better — then suddenly worsen again
In these cases, your GP may order a blood test, PCR swab, or chest X-ray to look for signs of Mycoplasma pneumoniae and rule out other illnesses.
While mycoplasma pneumonia often presents as a milder respiratory illness, treatment and recovery don’t always follow the same path as typical pneumonia or viral infections. The fact that it’s caused by an atypical bacterium — Mycoplasma pneumoniae — means that some common treatments won’t work, and recovery may be slower and more drawn out.
One of the biggest differences in treating mycoplasma pneumonia is choosing the right kind of antibiotic. Because M. pneumoniae lacks a cell wall — the very structure most antibiotics target — it doesn’t respond to drugs like penicillin or cephalosporins.
Instead, doctors usually prescribe antibiotics that act on the bacterial ribosomes, such as:
Macrolides (e.g. azithromycin, clarithromycin)
Tetracyclines (e.g. doxycycline — often used in adults)
Fluoroquinolones (used when other options are not suitable)
These antibiotics help reduce the bacterial load and speed up recovery. But timing matters — if you start antibiotics later in the illness, it may take longer to notice improvement, especially if the cough has already become entrenched.
Because symptoms tend to be milder (but more persistent), many people try to push through the illness. However, even “walking pneumonia” can take a toll on the lungs. Supportive care is still a vital part of recovery:
Plenty of rest: Don’t underestimate the fatigue — it can linger for weeks.
Hydration: Helps thin mucus and soothe irritated airways.
Lung-clearing support: Devices like AirPhysio may assist with mucus clearance, especially if you're experiencing wheezing or chest tightness.
Anti-inflammatory care: Paracetamol or ibuprofen can reduce inflammation, ease headaches, and help you sleep.
Even with antibiotics, many people report lingering symptoms for weeks after the infection clears. The most common of these include:
Dry, nagging cough
Shortness of breath during activity
Low energy or brain fog
Chest tightness or discomfort
This happens because mycoplasma pneumonia causes inflammation deep in the airways, and it can take time for your lungs to fully heal. People with asthma, COPD, or other chronic lung conditions may take longer to bounce back and are at higher risk of relapse or complications.
In some cases, post-infectious airway hyperresponsiveness (where the lungs remain overly sensitive) can cause symptoms to hang on for a month or more.
If your cough continues beyond 3–4 weeks, or if you’re experiencing difficulty breathing, chest pain, or unusual fatigue, it’s important to:
Revisit your GP
Rule out secondary infections
Consider a chest X-ray or spirometry (lung function test)
Long-term effects are rare in healthy adults, but proper follow-up helps ensure full recovery — especially if symptoms aren’t improving as expected.
Mycoplasma pneumonia may not always hit as hard or fast as other types of pneumonia, but that doesn’t mean it should be brushed off. Its slow-burning nature and overlapping symptoms with colds, flu, or even COVID-19 make it easy to miss — or misdiagnose. But recognising that your lingering cough and fatigue might be something more than “just a bug” is the first step toward recovery.
By understanding how this atypical pneumonia behaves — how it spreads, how it’s treated, and how long recovery may take — you’ll be better prepared to manage it or support someone going through it. With the right antibiotics, supportive care, and a bit of patience, most people recover fully. But if symptoms drag on, follow-up care matters.
And if you’re looking for natural ways to support your lungs during recovery, devices like AirPhysio may help clear mucus and improve breathing comfort — especially if you’re dealing with chest congestion, wheezing, or shortness of breath.